EUVIMEDEUVIMED entdecken
Crossref

Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma

Xuanren Shi, Xiaoqing Wu, Feng Yang, Xiaofang Hu, Qingzheng Kang iD

Molecular Nutrition & Food Research · 2025

DOI: 10.1002/mnfr.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Xuanren Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Environment and Female Reproductive Health, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Resveratrol, Killer Cells, Natural, Lymphoma, Non-Hodgkin, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Shenzhen Natural Science Foundation (Basic Research Project, HaiYa Young Scientist Foundation of Shenzhen University General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resveratrol (RSV) is a dietary polyphenolic compound with anticancer property. However, its clinical translation as an anticancer chemotherapeutic agent is hindered by multiple challenges. Chimeric antigen receptor (CAR) natural killer (NK) cell therapy has emerged as a promising immunotherapeutic strategy against refractory malignancies. The role of RSV in CAR NK cell therapy remains unexplored. This study pioneers the investigation of RSV's role in CAR NK immunotherapy. Specially, RSV preconditioning improved CAR NK cells’ resistance to oxidative stress, and augmented energetic metabolism in CAR NK cells. More importantly, the enhanced cytotoxicity against cancer cells of non‐Hodgkin lymphoma (NHL) and stronger cytokine secretions were observed in RSV‐treated anti‐CD19 CAR NK cells. In vivo tracking revealed RSV extended CAR NK tissue residency and enhanced therapeutic efficacy in NHL xenografts. RSV‐adjuvanted anti‐CD19 CAR NK therapy achieved an obvious reduction in intraperitoneal tumor burden and improvement in the mice survival. Our mechanistic investigation revealed that nuclear factor erythroid 2‐related factor 2 (NRF2) serves as a critical mediator in RSV‐induced functional augmentation of CAR NK cells. These findings established RSV as a potential polyphenol adjuvant capable of improving CAR NK therapy, providing a translatable strategy for polyphenols to overcome current limitations in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolKiller Cells, NaturalLymphoma, Non-HodgkinReceptors, Chimeric AntigenImmunotherapy, AdoptiveAnimalsHumansMiceCell Line, TumorNF-E2-Related Factor 2Oxidative StressXenograft Model Antitumor AssaysImmunotherapy

Stichwörter der Autor:innen

cancerchimeric antigen receptors (CAR)functional enhancementimmunotherapeuticspolyphenol

Substanzen

ResveratrolReceptors, Chimeric AntigenNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Research Center for Environment and Female Reproductive Health, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
  • Department of Hematology and Oncology, Shenzhen University General Hospital, Shenzhen, China.
  • Department of Orthopaedics and Traumatology, Shenzhen University General Hospital, Shenzhen, China.
  • BGI-Shenzhen, Shenzhen, China.

ORCID-Profile: Qingzheng Kang

Förderung

  • Shenzhen Natural Science Foundation (Basic Research Project
  • HaiYa Young Scientist Foundation of Shenzhen University General Hospital

Zitieren

APA

Shi, X., Wu, X., Yang, F., Hu, X., & Kang, Q. (2025). Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70112

Vancouver

Shi X, Wu X, Yang F, Hu X, Kang Q. Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70112

BibTeX
@article{Shi2025,
  author = {Shi, Xuanren and Wu, Xiaoqing and Yang, Feng and Hu, Xiaofang and Kang, Qingzheng},
  title = {Resveratrol Enhances CAR NK Cell Function in Cellular Immunotherapy of Non‐Hodgkin Lymphoma},
  journal = {Molecular Nutrition & Food Research},
  year = {2025},
  doi = {10.1002/mnfr.70112}
}
Kostenlos starten →